Holen Sie sich die Stockscreener-App
3.42
1.48%
0.05
Handel nachbörslich:
3.42
Schlusskurs vom Vortag:
$3.37
Offen:
$3.37
24-Stunden-Volumen:
1.31M
Relative Volume:
0.78
Marktkapitalisierung:
$284.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-36.95M
KGV:
-4.0714
EPS:
-0.84
Netto-Cashflow:
$-33.46M
1W Leistung:
-10.24%
1M Leistung:
-7.57%
6M Leistung:
+6.87%
1J Leistung:
-13.64%
1-Tages-Spanne:
$3.31
$3.52
1-Wochen-Bereich:
$3.305
$3.765
52-Wochen-Spanne:
$1.61
$5.37
Larimar Therapeutics Inc Stock (LRMR) Company Profile
Firmenname
Larimar Therapeutics Inc
Sektor
Branche
Telefon
844-511-9056
Adresse
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Vergleichen Sie LRMR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.42 | 280.01M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-29 | Eingeleitet | Truist | Buy |
| 2024-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-03 | Eingeleitet | Wedbush | Outperform |
| 2024-10-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-03 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-19 | Eingeleitet | Guggenheim | Buy |
| 2022-02-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-01 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Larimar Therapeutics Inc Aktie (LRMR) Neueste Nachrichten
How buybacks impact Larimar Therapeutics Inc. stock value2026 world cup usa national team third place match young talents high defensive line group prediction breakdown - ulpravda.ru
Leerink Partners assumes coverage on Larimar Therapeutics stock with Outperform rating - Investing.com Canada
Short Interest in Larimar Therapeutics, Inc. (NASDAQ:LRMR) Decreases By 19.2% - MarketBeat
Why Larimar Therapeutics Inc. stock could rally in 2025Quarterly Portfolio Summary & Safe Entry Trade Reports - moha.gov.vn
Comparing Altimmune (NASDAQ:ALT) & Larimar Therapeutics (NASDAQ:LRMR) - Defense World
Larimar heads to JPMorgan as rare disease program draws investor attention - MSN
Larimar Heads to JPMorgan as Rare Disease Program Draws Investor Attention - MyChesCo
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Should I hold or sell Larimar Therapeutics Inc. stock in 20252025 Sector Review & Smart Money Movement Tracker - Улправда
Will Larimar Therapeutics Inc. (ZA71) stock see valuation expansionMarket Activity Summary & Advanced Technical Signal Analysis - Улправда
How institutional buying supports Larimar Therapeutics Inc. stockJuly 2025 Update & Reliable Intraday Trade Plans - Улправда
Is Larimar Therapeutics Inc. stock a contrarian buyInsider Buying & Daily Technical Stock Forecast Reports - Улправда
Moving Averages: Can Larimar Therapeutics Inc. stock rebound after recent weakness2025 Earnings Surprises & Accurate Technical Buy Alerts - Улправда
Market Fear: How Larimar Therapeutics Inc. (ZA71) stock correlates with oil marketsJuly 2025 Outlook & Precise Swing Trade Entry Alerts - Улправда
How Larimar Therapeutics Inc. (ZA71) stock correlates with oil marketsJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - Улправда
Published on: 2025-12-20 00:54:00 - Улправда
Why Larimar Therapeutics Inc. stock appeals to analysts2025 Stock Rankings & Risk Controlled Stock Alerts - bolumsonucanavari.com
US Market Wrap: Will Larimar Therapeutics Inc. (ZA71) stock see valuation expansionMarket Growth Report & Short-Term Trading Alerts - Улправда
Published on: 2025-12-19 13:18:47 - ulpravda.ru
Published on: 2025-12-19 05:26:13 - Улправда
Is Larimar Therapeutics Inc. (ZA71) stock a buy during volatile marketsPrice Action & Comprehensive Market Scan Insights - Улправда
Why Larimar Therapeutics Inc. stock remains on buy lists2025 Sector Review & Risk Managed Investment Strategies - Улправда
Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Why Larimar Therapeutics Inc. stock is recommended by analystsPortfolio Gains Summary & AI Based Buy/Sell Signal Reports - Улправда
Larimar Therapeutics exchanges common stock for preferred shares in agreement with Blue Owl - Investing.com Australia
Larimar Therapeutics exchanges common stock for preferred shares in agreement with Blue Owl By Investing.com - Investing.com South Africa
Larimar Therapeutics Executes Strategic Stock Exchange Agreement - TipRanks
Larimar Therapeutics Earnings Notes - Trefis
Get in on Larimar Therapeutics Inc’s (LRMR) buy-in window today! - setenews.com
Can Larimar Therapeutics Inc. stock sustain market leadership2025 Winners & Losers & Weekly Return Optimization Alerts - Newser
How geopolitical risks impact Larimar Therapeutics Inc. (ZA71) stockMarket Rally & AI Enhanced Execution Alerts - Newser
Top 3 Health Care Stocks That May Rocket Higher In December - Benzinga
How Larimar Therapeutics Inc. (ZA71) stock behaves in tightening cyclesAnalyst Upgrade & Proven Capital Preservation Methods - Newser
Will Larimar Therapeutics Inc. (ZA71) stock recover faster than industry2025 Big Picture & Free AI Powered Buy and Sell Recommendations - Newser
Will Larimar Therapeutics Inc. (ZA71) stock profit from automation wave2025 Trade Ideas & Weekly Watchlist for Hot Stocks - Newser
Top investors say Larimar Therapeutics Inc (LRMR) ticks everything they need - Setenews
Why Larimar Therapeutics Inc. (ZA71) stock stays undervaluedWeekly Trend Recap & Comprehensive Market Scan Insights - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Larimar Therapeutic - The National Law Review
Is Larimar Therapeutics Inc a good long term investmentStock Rotation Strategies & High Return Capital Strategies - earlytimes.in
Short Covering May Lift Piccadily Sugar Allied Industries Limited in Near TermPrice Channel Trading & Small Budget Trading Tips - earlytimes.in
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Will Larimar Therapeutics Inc. stock outperform value stocks2025 Market WrapUp & Weekly Top Gainers Trade List - moha.gov.vn
Published on: 2025-11-27 11:17:59 - moha.gov.vn
Published on: 2025-11-26 23:31:58 - moha.gov.vn
Are Smart Investors Making the Right Decision? Larimar Therapeutics Inc (LRMR) - setenews.com
Larimar Therapeutics Advances Phase 1 Study on Nomlabofusp for Friedreich’s Ataxia - MSN
Should You Track Oswal Yarns Limited as a LongTerm Growth PlayTechnical Analysis Insights & Learn to Trade with Real-Time Feedback - earlytimes.in
Is Larimar Therapeutics Inc. stock a smart buy before Fed meetingForecast Cut & Daily Profit Focused Screening - newser.com
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data - MSN
Why Larimar Therapeutics Inc. (ZA71) stock stays on top picksMarket Growth Review & Risk Controlled Swing Alerts - newser.com
Finanzdaten der Larimar Therapeutics Inc-Aktie (LRMR)
Umsatz
Nettogewinn
Free Cashflow
ENV
28.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):